Sulzer's Inter-Op
This article was originally published in The Gray Sheet
Executive Summary
Recalled hip implant recipient Rhonda Silva files product liability lawsuit Jan. 19 through Lieff, Cabraser, Heimann & Bernstein against Sulzer Orthopedics parent Sulzer Medica in California Superior Court in Alameda County. Although Sulzer issued a Dec. 8 press release announcing the recall, the plaintiff alleges that the Swiss company failed to issue warnings of the defect to physicians and the general public following reports of the defective acetabular shells as early as October 1999 (1"The Gray Sheet" Jan. 22, 2001, p. 14)
You may also be interested in...
Sulzer Inter-Op Hip Shell Loosening Detected In 129 Patients Following Recall
The financial impact of Sulzer Orthopedics' Inter-Op acetabular shell hip implant recall Dec. 5 "will be more than offset" by a $32 mil. one-time payment from a separate litigation settlement to its Sulzer Spine-Tech subsidiary, the firm predicts.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.